SCHEMBL15511710

SCHEMBL15511710

COc1ccc(CNS(=O)(=O)CCc2ccc(-c3ccc(C(F)(F)F)cn3)cc2)c(OC)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 2/20 0.45
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ KIF11 P52732 1/20 0.40
▸ PPARG P37231 2/20 0.40
▸ CYP1A2 P05177 3/20 0.38
▸ CYP3A4 P08684 3/20 0.38
▸ CYP2D6 P10635 3/20 0.38
▸ ACP1 P24666 2/20 0.38
▸ USP2 O75604 2/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ TSHR P16473 2/20 0.38
▸ MAPT P10636 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ CLK4 Q9HAZ1 1/20 0.37
▸ MMP8 P22894 1/20 0.37
▸ MMP12 P39900 1/20 0.37
▸ MMP13 P45452 1/20 0.37
▸ APLNR P35414 1/20 0.37
▸ ROCK2 O75116 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12494022 0.84 GAA (0.40) TP53MEN1KMT2AKIF11ACP1
SCHEMBL12492849 0.81 APLNR (0.47) TP53MEN1KMT2AMMP8MMP12
SCHEMBL15511713 0.78 KIF11 (0.43) TP53MEN1KMT2AKIF11CASP3
SCHEMBL12525710 0.76 APLNR (0.49) TP53MEN1KMT2AMAPTMMP8
SCHEMBL12493456 0.76 MMP8 (0.50) TP53MEN1KMT2AMMP8MMP12
SCHEMBL12492811 0.76 ALDH1A1 (0.53) TP53MEN1KMT2AMAPTMMP8
SCHEMBL20207377 0.76 TP53 (0.54) TP53MEN1KMT2ACYP1A2CYP3A4
SCHEMBL15511711 0.74 KIF11 (0.43) TP53MEN1KMT2AKIF11
SCHEMBL30739004 0.71 RXFP1 (0.53) MEN1KMT2AKIF11ACP1CASP3
SCHEMBL913930 0.71 RXFP1 (0.53) MEN1KMT2AKIF11ACP1CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8846666-B2 Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof SANOFI (FR) 2014-09-30 — — US disclosed
US-20140066437-A1 OXATHIAZINE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL OR HETEROMETHYLENE GROUPS, METHOD FOR PRODUCING THEM, THEIR USE AS MEDICINE AND DRUG CONTAINING SAID DERIVATIVES AND THE USE THEREOF SANOFI (FR) 2014-03-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140066437-A1 OXATHIAZINE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL OR HETEROMETHYLENE GROUPS, METHOD FOR PRODUCING THEM, THEIR USE AS MEDICINE AND DRUG CONTAINING SAID DERIVATIVES AND THE USE THEREOF SLC5A2, SLC5A1, CYP11B2 TP53 4218/4885MEN1 1337/4885KMT2A 2312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback